Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1963 Sep;42(9):1411–1420. doi: 10.1172/JCI104826

REDUCED VASCULAR RESPONSE TO ANGIOTENSIN II IN SECONDARY HYPERALDOSTERONISM*

C I Johnston 1, Anthony D Jose 1
PMCID: PMC289416  PMID: 14060986

Full text

PDF
1411

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAEZ S., MAZUR A., SHORR E. Hepatorenal factors in circulatory homeostasis. XX. Antidiuretic action of hepatic vasodepressor, VDM (ferritin). Am J Physiol. 1950 Jul 1;162(1):198–212. doi: 10.1152/ajplegacy.1950.162.1.198. [DOI] [PubMed] [Google Scholar]
  2. BLAIR-WEST J. R., COGHLAN J. P., DENTON D. A., GODING J. R., MUNRO J. A., PETERSON R. E., WINTOUR M. Humoral stimulation of adrenal cortical secretion. J Clin Invest. 1962 Aug;41:1606–1627. doi: 10.1172/JCI104619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BOCK K. D., GROSS F. Renin and angiotensin tachyphylaxis. Circ Res. 1961 Sep;9:1044–1050. doi: 10.1161/01.res.9.5.1044. [DOI] [PubMed] [Google Scholar]
  4. BOHR D. F., BRODIE D. C., CHEU D. H. Effect of electrolytes on arterial muscle contraction. Circulation. 1958 Apr;17(4 Pt 2):746–749. doi: 10.1161/01.cir.17.4.746. [DOI] [PubMed] [Google Scholar]
  5. CARPENTER C. C., DAVIS J. O., AYERS C. R. Relation of renin, angiotensin II, and experimental renal hypertension to aldosterone secretion. J Clin Invest. 1961 Nov;40:2026–2042. doi: 10.1172/JCI104429. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CONWAY J. Vascular reactivity in experimental hypertension measured after hexamethonium. Circulation. 1958 Apr;17(4 Pt 2):807–810. doi: 10.1161/01.cir.17.4.807. [DOI] [PubMed] [Google Scholar]
  7. DAVIS J. O., CARPENTER C. C., AYERS C. R. Relation of renin and angiotensin II to the control of aldosterone secretion. Circ Res. 1962 Jul;11:171–184. doi: 10.1161/01.res.11.1.171. [DOI] [PubMed] [Google Scholar]
  8. DAVIS J. O., HARTROFT P. M., TITUS E. O., CARPENTER C. C., AYERS C. R., SPIEGEL H. E. The role of the renin-angiotensin system in the control of aldosterone secretion. J Clin Invest. 1962 Feb;41:378–389. doi: 10.1172/JCI104492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. ECKSTEIN J. W., ABBOUD F. M., PEREDA S. A. The effect of norepinephrine on cardiac output, arterial blood pressure, and heart rate in dogs treated with chlorothiazide. J Clin Invest. 1962 Aug;41:1578–1583. doi: 10.1172/JCI104615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. EISENBERG S. Blood volume in patients with Laennec's cirrhosis of the liver as determined by radioactive chromium-tagged red cells. Am J Med. 1956 Feb;20(2):189–195. doi: 10.1016/0002-9343(56)90189-9. [DOI] [PubMed] [Google Scholar]
  11. FINNERTY F. A., Jr Hemodynamics of angiotensin in man. Circulation. 1962 Jan;25:255–258. doi: 10.1161/01.cir.25.1.255. [DOI] [PubMed] [Google Scholar]
  12. FREIS E. D., WANKO A., SCHNAPER H. W., FROHLICH E. D. Mechanism of the altered blood pressure responsiveness produced by chlorothiazide. J Clin Invest. 1960 Aug;39:1277–1281. doi: 10.1172/JCI104143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. FRIEDMAN S. M., ALLARDYCE D. B. Sodium and tension in artery segment. Circ Res. 1962 Jul;11:84–89. [PubMed] [Google Scholar]
  14. GENEST J., BIRON P., KOIW E., NOWACZYNSKI W., BOUCHER R., CHRETIEN M. Studies of the pathogenesis of human hypertension. The adrenal cortex and renal pressor mechanism. Ann Intern Med. 1961 Jul;55:12–28. doi: 10.7326/0003-4819-55-1-12. [DOI] [PubMed] [Google Scholar]
  15. HARTROFT W. S., HARTROFT P. M. New approaches in the study of cardiovascular disease: aldosterone, renin, hypertension and juxtaglomerular cells. Fed Proc. 1961 Dec;20:845–854. [PubMed] [Google Scholar]
  16. KAPLAN N. M., BARTER F. C. The effect of ACTH, renin, angiotensin II, and various precursors on biosynthesis of aldosterone by adrenal slices. J Clin Invest. 1962 Apr;41:715–724. doi: 10.1172/JCI104530. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. LARAGH J. H., ANGERS M., KELLY W. G., LIEBERMAN S. Hypotensive agents and pressor substances. The effect of epinephrine, norepinephrine, angiotensin II, and others on the secretory rate of aldosterone in man. JAMA. 1960 Sep 17;174:234–240. doi: 10.1001/jama.1960.03030030014003. [DOI] [PubMed] [Google Scholar]
  18. LARAGH J. H. Hormones and the pathogenesis of congestive heart failure: vasopressin, aldosterone, and angiotensin II. Further evidence for renal-adrenal interaction from studies in hypertension and in cirrhosis. Circulation. 1962 Jun;25:1015–1023. doi: 10.1161/01.cir.25.6.1015. [DOI] [PubMed] [Google Scholar]
  19. LARAGH J. H. Interrelationships between angiotensin, norepinephrine, epinephrine, aldosterone secretion, and electrolyte metabolism in man. Circulation. 1962 Jan;25:203–211. doi: 10.1161/01.cir.25.1.203. [DOI] [PubMed] [Google Scholar]
  20. LARAGH J. H. The mode of action and use of chlorothiazide and related compounds. Circulation. 1962 Jul;26:121–132. doi: 10.1161/01.cir.26.1.121. [DOI] [PubMed] [Google Scholar]
  21. LAUWERS P., CONWAY J. Effect of long-term treatment with chlorothiazide on body fluids, serum electrolytes, and exchangeable sodium in hypertensive patients. J Lab Clin Med. 1960 Sep;56:401–408. [PubMed] [Google Scholar]
  22. MULROW P. J., GANONG W. F., CERA G., KULJIAN A. The nature of the aldosterone-stimulating factor in dog kidneys. J Clin Invest. 1962 Mar;41:505–518. doi: 10.1172/JCI104504. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. NAPODANO R. J., CALIVA F. S., LYONS C., DESIMONE J., LYONS R. H. The reactivity to angiotensin of rabbit aorta strips after either alterations of external sodium environment or direct addition of benzydroflumethiazide. Am Heart J. 1962 Oct;64:498–502. doi: 10.1016/0002-8703(62)90035-2. [DOI] [PubMed] [Google Scholar]
  24. ORBISON J. L. Failure of chlorothiazide to influence tissue electrolytes in hypertensive and non-hypertensive nephrectomized dogs. Proc Soc Exp Biol Med. 1962 May;110:161–164. doi: 10.3181/00379727-110-27454. [DOI] [PubMed] [Google Scholar]
  25. PAGE I. H., BUMPUS F. M. Angiotensin. Physiol Rev. 1961 Apr;41:331–390. doi: 10.1152/physrev.1961.41.2.331. [DOI] [PubMed] [Google Scholar]
  26. SCHREIBER S. S., ROTHSCHILD M. A. Blood volume and heart disease. Prog Cardiovasc Dis. 1962 May;4:565–585. doi: 10.1016/s0033-0620(62)80009-7. [DOI] [PubMed] [Google Scholar]
  27. TOBIAN L., JANECEK J., FOKER J., FERREIRA D. Effect of chlorothiazide on renal juxtaglomerular cells and tissue electrolytes. Am J Physiol. 1962 May;202:905–908. doi: 10.1152/ajplegacy.1962.202.5.905. [DOI] [PubMed] [Google Scholar]
  28. VARNAUSKAS E., CRAMER G., MALMCRONA R., WERKO L. Effect of chlorothiazide on blood pressure and blood flow at rest and on exercise in patients with arterial hypertension. Clin Sci. 1961 Jun;20:407–416. [PubMed] [Google Scholar]
  29. Waterfield R. L. CHANGES IN BLOOD VOLUME IN PATIENTS WITH EDEMA OF RENAL ORIGIN. J Clin Invest. 1931 Feb;9(4):589–599. doi: 10.1172/JCI100323. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES